The top documents tagged [development of new drugs]

TB/HIV Research Priorities in Resource- Limited Settings Where we are now and some suggestions for where to go Paul Nunn 14-15 February 2005.

1 Supersensitive magnetocardiographic system for early recognition, precise diagnostics and monitoring of heart diseases 12.10.2006 Kiev Dr.Volodymyr Sosnytskyy.

Gene Finding in Clinical Trial Populations Tom Price SGDP 18 th Feb 2009

The legal ecology of resistance: why normal IP rules should be adjusted for antibiotics Kevin Outterson [email protected] Oxford 25 April 2014.

1 An Ecosystem for Competitiveness and Innovation Hervé Mouren, TERATEC Managing Director November, 2012.

U-BIOPRED Unbiased BIOmarkers for the PREDiction of respiratory disease outcome Dr Louise Fleming.

OPTIMISATION SOLUTIONS FOR VALIDATION PROCEDURES IN THE QUALITY CONTROL OF ENANTIOMERS. CHIRALITY TESTS FOR ANTIDEPRESSANTS CITALOPRAM AND VENLAFAXINE.

Health Informatics and Broadband Presentation

Mip 180111

AMIF2014 – [Plenaria] Luigi Ambrosio, Approccio integrato per lo sviluppo di materiali e sistemi avanzati

Applications of pharmacokinetics in new drug development,dosage form design & ndds

Molecular genetics in soft tissue